These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 14534524

  • 1. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, Zhou HH.
    Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
    [Abstract] [Full Text] [Related]

  • 2. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J, Liu ZQ, Yu BN, Xu FH, Mo W, Zhou G, Liu YZ, Li Q, Zhou HH.
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [Abstract] [Full Text] [Related]

  • 3. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
    Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, Brodde OE.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):2111-5. PubMed ID: 16325050
    [Abstract] [Full Text] [Related]

  • 4. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hamilton KK, Aranda JM, Hill JA, Yarandi HN, Walker JR, Phillips MS, Gelfand CA, Johnson JA.
    Clin Pharmacol Ther; 2005 Mar 06; 77(3):127-37. PubMed ID: 15735607
    [Abstract] [Full Text] [Related]

  • 5. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG, Puckett BJ, Allen RC, Castillo IG, Leffler CT.
    Ophthalmology; 2005 Dec 06; 112(12):2131-6. PubMed ID: 16325708
    [Abstract] [Full Text] [Related]

  • 6. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
    Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF.
    Clin Pharmacol Ther; 2003 Jul 06; 74(1):44-52. PubMed ID: 12844134
    [Abstract] [Full Text] [Related]

  • 7. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ.
    Clin Pharmacol Ther; 1999 Dec 06; 66(6):594-601. PubMed ID: 10613615
    [Abstract] [Full Text] [Related]

  • 8. Effect of the Arg389Gly β₁-adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype-dependent response to metoprolol treatment.
    Petersen M, Andersen JT, Jimenez-Solem E, Broedbaek K, Hjelvang BR, Henriksen T, Frandsen E, Forman JL, Torp-Pedersen C, Køber L, Poulsen HE.
    Clin Exp Pharmacol Physiol; 2012 Sep 06; 39(9):779-85. PubMed ID: 22703382
    [Abstract] [Full Text] [Related]

  • 9. Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.
    Beitelshees AL, Zineh I, Yarandi HN, Pauly DF, Johnson JA.
    Pharmacogenomics J; 2006 Sep 06; 6(3):174-8. PubMed ID: 16402084
    [Abstract] [Full Text] [Related]

  • 10. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population.
    Mahesh Kumar KN, Ramu P, Rajan S, Shewade DG, Balachander J, Adithan C.
    J Cardiovasc Pharmacol; 2008 Nov 06; 52(5):459-66. PubMed ID: 19033826
    [Abstract] [Full Text] [Related]

  • 11. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
    O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ.
    Clin Sci (Lond); 2000 Sep 06; 99(3):233-8. PubMed ID: 11787477
    [Abstract] [Full Text] [Related]

  • 12. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
    Beitelshees AL, Zineh I, Yarandi HN, Pauly DF, Johnson JA.
    Pharmacotherapy; 2006 Sep 06; 26(9):1247-54. PubMed ID: 16945046
    [Abstract] [Full Text] [Related]

  • 13. Job strain, job demands and adrenergic beta1-receptor-polymorphism: a possible interaction affecting blood pressure in men.
    Ohlin B, Berglund G, Nilsson PM, Melander O.
    J Hypertens; 2008 Aug 06; 26(8):1583-9. PubMed ID: 18622236
    [Abstract] [Full Text] [Related]

  • 14. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
    Yu WP, Lou M, Deng B, Song HM, Wang HB.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep 06; 34(9):776-80. PubMed ID: 17217681
    [Abstract] [Full Text] [Related]

  • 15. The Arg389Gly beta1-adrenoceptor polymorphism does not affect cardiac effects of exercise after parasympathetic inhibition by atropine.
    Leineweber K, Bruck H, Temme T, Heusch G, Philipp T, Brodde OE.
    Pharmacogenet Genomics; 2006 Jan 06; 16(1):9-13. PubMed ID: 16344717
    [Abstract] [Full Text] [Related]

  • 16. The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.
    Muszkat M, Hoofien A, Orlanski-Meyer E, Makhoul H, Porat E, Davidson EM, Blotnick S, Caraco Y.
    Pharmacogenet Genomics; 2013 Jan 06; 23(1):25-8. PubMed ID: 23114278
    [Abstract] [Full Text] [Related]

  • 17. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease.
    Defoor J, Martens K, Zielinska D, Matthijs G, Van Nerum H, Schepers D, Fagard R, Vanhees L.
    Eur Heart J; 2006 Apr 06; 27(7):808-16. PubMed ID: 16421173
    [Abstract] [Full Text] [Related]

  • 18. Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea.
    Börgel J, Schulz T, Bartels NK, Epplen JT, Büchner N, Rump LC, Huesing A, Sanner BM, Mügge A.
    Clin Sci (Lond); 2006 Jan 06; 110(1):117-23. PubMed ID: 16122377
    [Abstract] [Full Text] [Related]

  • 19. The effects of aerobic fitness and beta1-adrenergic receptor blockade on cardiac work during dynamic exercise.
    Hawkins MN, Barnes Q, Purkayastha S, Eubank W, Ogoh S, Raven PB.
    J Appl Physiol (1985); 2009 Feb 06; 106(2):486-93. PubMed ID: 19036891
    [Abstract] [Full Text] [Related]

  • 20. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics.
    Kirchheiner J, Heesch C, Bauer S, Meisel C, Seringer A, Goldammer M, Tzvetkov M, Meineke I, Roots I, Brockmöller J.
    Clin Pharmacol Ther; 2004 Oct 06; 76(4):302-12. PubMed ID: 15470329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.